Posted by Michael Wonder on 14 May 2025
FDA fast tracks therapy for radiation-induced dry mouth
7 May 2025 - A therapy under development at the University of Wisconsin School of Medicine and Public Health to treat a common side effect of radiation therapy recently got a boost from the FDA.
The novel cell therapy, designed to treat xerostomia, commonly called dry mouth, caused by radiation therapy, was granted fast track designation by the federal agency. The therapy, currently in a Phase 1 clinical trial at the UW Health | Carbone Cancer Center, was developed by the Program for Advanced Cell Therapy, a partnership between UW Health and the UW School of Medicine and Public Health.
